skip to Main Content

Montefiore And Einstein Investigators Deliver New Hope For Treating Deadly Cancers

Newsfeed image, light gray text on dark gray background

Members of the Department of Radiation Oncology at Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine‘s NCI–designated Albert Einstein Cancer Center will present new study findings at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO) that will advance treatment of pancreatic and anal cancers.

Researchers will also lead a discussion about implementing a cost efficient workflow for treatment of the most advanced forms of throat cancer. These are some of the highlights at ASTRO 2016, which is taking place at the Boston Convention Center from September 25-28.

“For too long people with pancreatic cancer have faced poor prognoses, with immunotherapies offering little hope,” said Shalom Kalnicki, M.D., professor and chair, Department of Radiation Oncology, Montefiore-Einstein. “By combining radiation therapy and immunotherapy we have obtained promising results that indicate that we can change how the body reacts to cancer cells and that we have the potential to enhance the effectiveness of immunotherapies in fighting diseases that are difficult to treat. We are excited about this progress, which we believe represents the future of effective cancer therapies. We look forward to sharing these findings and presenting new recommendations for effectively treating several cancers.” Read more . . .

Back To Top